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Within days of taking office, Colin
Blakemore, former professor of
physiology at the University of
Oxford and now head of the
Medical Research Council, was on
the road. In the first few months of
his appointment he is spending as
much time as possible learning at
first hand about the strategies for
medical research in UK
universities, sharing his initial
thoughts about the role of the
MRC, and listening to the views of
the medical research community.
He plans to visit 16 universities by
early next year and expects a
rough ride. “At each university I’m
including a 90-minute open
meeting when any researcher can
engage in a free dialogue on any
critical issue,” he says.
Blakemore’s strategy follows a
troubled recent past for the council.
Earlier this year, the council was
heavily criticised by the House of
Commons select committee on
science and technology, and
accused of being guilty of poor
financial management and
planning, misguided research
strategies and inadequate
communication. Plans for the future
of the council’s National Institute
for Medical Research in London
have also drawn fire.
“I think the most alarming thing
about the select committee report
on the MRC was the fact that most
scientists who gave evidence did
so anonymously. That implies
researchers are afraid to express
openly what they think of the
council they work for. I find that a
very worrying sign, and that is
something we have to get rid of.
We have all got to be able to speak
out.”
Funding is a chronic issue and
he says it is still not back to the
level of the 1980s despite recent
increases.
The key problem for his
university audiences is the lack of
grants for top-rate projects. “There
has been a decline in
response–mode funding,” he says.
“We need a more predictable
budget and need to be more open
and engaging in discussion.”
Blakemore’s other early priority
is to raise the profile of MRC
research and in a press release on
the first day of his new job he
warned that scientists must
communicate with the public if
they are to be trusted. Few
scientists could have such
authority for the plea. Blakemore
has spent many years under attack
from animal rights activists for the
experiments he has carried out and
his insistence on defending their
medical justification to the public,
for which he has won considerable
respect from other scientists. 
Blakemore hopes these early
moves will help the council. “The
MRC staff are a fantastic bunch of
people. We spend only 3% of our
budget on administration. It is a
very tight ship – in some areas too
tight,” he says. 
But while many welcome
Blakemore’s appointment, he
warns: “it is important to be aware
of expectation management – I
can’t wave a wand or work
miracles. The MRC simply doesn’t
have enough money”.
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Listening head: Colin Blakemore, the new chief executive of the Medical Research
Council, is determined to listen to researchers and ensure that scientists are able to air
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